Preferred Name |
macitentan |
|
Synonyms |
Actelion-1 opsumit ACT-064992 ACT 064992 ACT064992 N-(5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)pyrimidin-4-yl)-N'-propylaminosulfonamide |
|
ID |
http://purl.bioontology.org/ontology/MESH/C533860 |
|
altLabel |
Actelion-1 opsumit ACT-064992 ACT 064992 ACT064992 N-(5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)pyrimidin-4-yl)-N'-propylaminosulfonamide |
|
cui |
C2606557 C3692493 C2606556 C4282250 |
|
HM |
D011743 D013449 |
|
Inverse of RB |
Z9K9Y9WMVL |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20140721 |
|
MeSH Frequency |
227 |
|
MMR |
20171016 |
|
notation |
C533860 |
|
PA |
D065131 D065130 |
|
prefLabel |
macitentan |
|
SC |
1 |
|
Scope Statement |
structure in first source |
|
SRC |
J Pharmacol Exp Ther 2008 Dec;327(3):736-45 |
|
TERMUI |
T732153 T000862625 T732152 T732157 T732156 T732155 T732154 |
|
TH |
NLM (2008) USAN (19XX) INN (19XX) FDA SRS (2015) NLM (2014) |
|
tui |
T109 T121 |
Create mapping